SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
SEC Accession No. 0001193125-09-050984
Filing Date
2009-03-11
Accepted
2009-03-11 17:16:58
Documents
6
Period of Report
2008-12-27
Filing Date Changed
2009-03-11

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 848607
2 CHANGE OF CONTROL SEVERANCE AGREEMENT dex1028.htm EX-10.28 25926
3 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM dex23.htm EX-23 2869
4 RULE 13A-14(A)/15D-14(A) CERTIFICATION dex311.htm EX-31.1 6746
5 SECTION 1350 CERTIFICATION dex32.htm EX-32 3475
6 GRAPHIC g76381g52t30.jpg GRAPHIC 40109
  Complete submission text file 0001193125-09-050984.txt   944695
Mailing Address 5800 PARK OF COMMERCE BLVD NW STE 322 BOCA RATON FL 33487
Business Address 5800 PARK OF COMMERCE BLVD N W STE 322 BOCA RATON FL 33487 5619895800
NABI BIOPHARMACEUTICALS (Filer) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1225
Type: 10-K | Act: 34 | File No.: 000-04829 | Film No.: 09673301
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1